H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 70 Citations 17,306 395 World Ranking 16202 National Ranking 182

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Type 2 diabetes

His primary areas of investigation include Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Glucagon-like peptide-1. His Type 2 Diabetes Mellitus research extends to the thematically linked field of Internal medicine. His research in Glucagon, Insulin, Incretin, Glucagon secretion and Postprandial are components of Endocrinology.

His Type 2 diabetes research includes elements of Meta-analysis, Adverse effect, Obesity and Gastroenterology. His study in Glucagon-like peptide-1 is interdisciplinary in nature, drawing from both Gastrointestinal hormone, Secretion, Elisa kit and Detection limit. His studies in Insulin resistance integrate themes in fields like Gut flora, Metabolic syndrome and Carbohydrate metabolism.

His most cited work include:

  • Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials (563 citations)
  • Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity (309 citations)
  • Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity (309 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Glucagon. His research links Glucagon-like peptide-1 with Internal medicine. Glucagon secretion, Insulin resistance, Glucose tolerance test, Type 2 Diabetes Mellitus and Hypoglycemia are the primary areas of interest in his Endocrinology study.

In his work, Overweight is strongly intertwined with Weight loss, which is a subfield of Type 2 diabetes. His work on Type 1 diabetes and Glucose homeostasis as part of general Diabetes mellitus study is frequently linked to Context and Crossover study, bridging the gap between disciplines. His research integrates issues of Carbohydrate metabolism and Area under the curve in his study of Postprandial.

He most often published in these fields:

  • Internal medicine (87.73%)
  • Endocrinology (67.61%)
  • Type 2 diabetes (44.47%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (87.73%)
  • Endocrinology (67.61%)
  • Type 2 diabetes (44.47%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Postprandial. In the field of Internal medicine, his study on Glucagon, Insulin and Hypoglycemia overlaps with subjects such as Crossover study. His research brings together the fields of Area under the curve and Endocrinology.

Filip K. Knop focuses mostly in the field of Type 2 diabetes, narrowing it down to matters related to Intensive care medicine and, in some cases, Individualized treatment. The various areas that he examines in his Diabetes mellitus study include Body mass index and Hazard ratio. His research in Postprandial intersects with topics in Meal, Glucagon-like peptide-1 and Receptor, Antagonist, Receptor antagonist.

Between 2019 and 2021, his most popular works were:

  • Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists (16 citations)
  • L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling (12 citations)
  • GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals. (11 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Type 2 diabetes

Filip K. Knop mainly focuses on Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Incretin. Internal medicine is closely attributed to Gastroenterology in his work. His Endocrinology study often links to related topics such as Antagonist.

His Type 2 diabetes research incorporates themes from Type 1 diabetes, Obesity and Clinical pharmacology, Bioinformatics. His work carried out in the field of Diabetes mellitus brings together such families of science as Odds ratio and Case-control study. Filip K. Knop has researched Incretin in several fields, including Area under the curve and Glucagon-like peptide 1 receptor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

Tina Vilsbøll;Mikkel Christensen;Anders E Junker;Filip K Knop.
BMJ (2012)

872 Citations

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

P. V. Højberg;P. V. Højberg;T. Vilsbøll;R. Rabøl;F. K. Knop.
Diabetologia (2009)

426 Citations

Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

Filip K. Knop;Tina Vilsbøll;Patricia V. Højberg;Steen Larsen.
Diabetes (2007)

412 Citations

Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

Anne Vrieze;Carolien Out;Susana Fuentes;Lisanne Jonker.
Journal of Hepatology (2014)

406 Citations

Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.

Ruud S. Kootte;Evgeni Levin;Jarkko Salojärvi;Loek P. Smits.
Cell Metabolism (2017)

374 Citations

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

T. Vilsbøll;F. K. Knop;T. Krarup;A. Johansen.
The Journal of Clinical Endocrinology and Metabolism (2003)

278 Citations

Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans

Mikkel Christensen;Louise Vedtofte;Jens J. Holst;Tina Vilsbøll.
Diabetes (2011)

270 Citations

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

S. Calanna;S. Calanna;M. Christensen;J. J. Holst;B. Laferrère.
Diabetologia (2013)

256 Citations

Recovery of gut microbiota of healthy adults following antibiotic exposure

Albert Palleja;Kristian H Mikkelsen;Sofia K Forslund;Alireza Kashani.
Nature microbiology (2018)

254 Citations

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.

Kristine J. Hare;Tina Vilsbøll;Meena Asmar;Carolyn F. Deacon.
Diabetes (2010)

253 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Filip K. Knop

Jens J. Holst

Jens J. Holst

University of Copenhagen

Publications: 291

Sten Madsbad

Sten Madsbad

Copenhagen University Hospital

Publications: 94

Michael Horowitz

Michael Horowitz

University of Adelaide

Publications: 87

Carolyn F. Deacon

Carolyn F. Deacon

University of Copenhagen

Publications: 69

Karen L. Jones

Karen L. Jones

University of Adelaide

Publications: 66

Fiona M. Gribble

Fiona M. Gribble

University of Cambridge

Publications: 55

Frank Reimann

Frank Reimann

University of Cambridge

Publications: 54

Peter R. Flatt

Peter R. Flatt

University of Ulster

Publications: 53

Bo Ahrén

Bo Ahrén

Lund University

Publications: 53

Michael A. Nauck

Michael A. Nauck

Ruhr University Bochum

Publications: 47

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 44

Mette M. Rosenkilde

Mette M. Rosenkilde

University of Copenhagen

Publications: 40

Carel W. le Roux

Carel W. le Roux

University College Dublin

Publications: 38

Fredrik Bäckhed

Fredrik Bäckhed

University of Gothenburg

Publications: 38

David A. D'Alessio

David A. D'Alessio

Duke University

Publications: 38

Juris J. Meier

Juris J. Meier

Ruhr University Bochum

Publications: 36

Something went wrong. Please try again later.